Affiliation:
1. Liver Diseases Unit, Departments of Medicine and
2. Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada R3E 3P5
Abstract
GABA is a potent inhibitory neurotransmitter that binds to heterooligomeric receptors in the mammalian brain. In a previous study, we documented specific GABA binding to isolated rat hepatocytes that resulted in inhibition of hepatocyte proliferation. The purpose of the present study was to define the nature of hepatic GABAA receptors and to document their expression during rapid liver growth (after partial hepatectomy). PCRs with gene-specific primers derived from published sequences were performed with Marathon-ready human and rat liver cDNA. Two GABAA receptor subunit types (β3 and ε) were expressed in human liver and one subunit type (β3) in rat liver. PCR amplification of the human GABAA receptorβ3-subunit produced a single product (molecular mass 53–59 kDa). In the case of the ε-subunit, two PCR products were identified. After partial hepatectomy, GABAA receptorβ3-subunit expression inversely correlated with regenerative activity ( r = −0.527, P = 0.006). In conclusion, these results indicate that in the human liver GABAA receptors consist of the β3- and ε-subunit types, whereas in the rat liver only the β3-subunit type is expressed. The results also support the hypothesis that GABAergic activity serves to maintain hepatocytes in a quiescent state.
Publisher
American Physiological Society
Subject
Physiology (medical),Gastroenterology,Hepatology,Physiology
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献